Applied BioCode Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 78.48 million compared to TWD 107.75 million a year ago. Net loss was TWD 61.16 million compared to TWD 31.58 million a year ago. Basic loss per share from continuing operations was TWD 0.75 compared to TWD 0.39 a year ago. Diluted loss per share from continuing operations was TWD 0.75 compared to TWD 0.39 a year ago.
For the six months, sales was TWD 161.19 million compared to TWD 161.8 million a year ago. Net loss was TWD 111.89 million compared to TWD 105.41 million a year ago. Basic loss per share from continuing operations was TWD 1.37 compared to TWD 1.29 a year ago. Diluted loss per share from continuing operations was TWD 1.37 compared to TWD 1.29 a year ago.